StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Triethylamine → tert-Butyl {5-[8-{4-[(dimethylamino)(oxo)acetyl]piperazin-1-yl}-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl]pyrimidin-2-yl}carbamate

HRID 421375
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 421375
[CH3:1][N:2]([CH3:8])[C:3](=[O:7])[C:4](O)=[O:5].O.OC1C2N=NNC=2C=CC=1.[C:20]([O:24][C:25](=[O:59])[NH:26][C:27]1[N:32]=[CH:31][C:30]([C:33]2[N:41]=[C:40]3[C:36]([N:37]=[C:38]([N:47]4[CH2:52][CH2:51][NH:50][CH2:49][CH2:48]4)[N:39]3[CH2:42][C:43]([F:46])([F:45])[F:44])=[C:35]([N:53]3[CH2:58][CH2:57][O:56][CH2:55][CH2:54]3)[N:34]=2)=[CH:29][N:28]=1)([CH3:23])([CH3:22])[CH3:21].Cl.C(N=C=NCCCN(C)C)C.C(N(CC)CC)C>O1CCCC1>[CH3:1][N:2]([C:3](=[O:7])[C:4]([N:50]1[CH2:49][CH2:48][N:47]([C:38]2[N:39]([CH2:42][C:43]([F:45])([F:46])[F:44])[C:40]3[C:36]([N:37]=2)=[C:35]([N:53]2[CH2:58][CH2:57][O:56][CH2:55][CH2:54]2)[N:34]=[C:33]([C:30]2[CH:31]=[N:32][C:27]([NH:26][C:25](=[O:59])[O:24][C:20]([CH3:23])([CH3:21])[CH3:22])=[N:28][CH:29]=2)[N:41]=3)[CH2:52][CH2:51]1)=[O:5])[CH3:8]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 8471TriethylamineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2760995N,N-Dimethyloxamic acidHCID 59333500tert-Butyl{5-[6-morpholin-4-yl-8-piperazin-1-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl]pyrimidin-2-yl}carbamateHCID 178526939HCID 178526939, Verbindung

Produkt 1

HCID 59333553
tert-Butyl {5-[8-{4-[(dimethylamino)(oxo)acetyl]piperazin-1-yl}-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl]pyrimidin-2-yl}carbamate
Ausbeute 84 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

N,N-Dimethyl-oxalamic acid (34 mg, 0.29 mmol), hydroxybenzotriazole hydrate (45 mg, 0.29 mmol), and tetrahydrofuran (5 ml) were added to tert-butyl{5-[6-morpholin-4-yl-8-piperazin-1-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl]pyrimidin-2-yl}carbamate (150 mg, 0.27 mmol). 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (56 mg, 0.29 mmol) and triethylamine (74 μl, 0.53 mmol) were added and the resulting mixture was stirred for 18 hours. The reaction mixture was partitioned with ethyl acetate and water and the organic layer was washed with saturated aqueous sodium bicarbonate solution and dried over magnesium sulfate. The solvent was evaporated under reduced pressure and then the residue was purified by silica gel chromatography (chloroform:methanol=19:1) to give the title compound (148 mg, 84%) as a white solid.

Aufarbeitung

  1. customThe reaction mixture was partitioned with ethyl acetate and water
  2. washthe organic layer was washed with saturated aqueous sodium bicarbonate solution
  3. dry with materialdried over magnesium sulfate
  4. customThe solvent was evaporated under reduced pressure
  5. customthe residue was purified by silica gel chromatography (chloroform:methanol=19:1)

Quellen und Nachweise

ORD-Eintrag
ord-a2aaf61aefb144bd9c5ee2247e46db3f
Quelldatensatz
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08097622B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion